相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。From the ashes of Ewing-like sarcoma: A contemporary update of the classification, immunohistochemistry, and molecular genetics of round cell sarcomas
Michael E. Kallen et al.
SEMINARS IN DIAGNOSTIC PATHOLOGY (2022)
Fusion transcripts as liquid biopsy markers in alveolar rhabdomyosarcoma and synovial sarcoma: A report of the Cooperative Weichteilsarkom Studiengruppe (CWS)
Sabine Stegmaier et al.
PEDIATRIC BLOOD & CANCER (2022)
Survival outcomes of patients with localized FOXO1 fusion-positive rhabdomyosarcoma treated on recent clinical trials: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group
Christine M. Heske et al.
CANCER (2021)
Germline Cancer Predisposition Variants in Pediatric Rhabdomyosarcoma: A Report From the Children's Oncology Group
He Li et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2021)
Immunohistochemical detection of PAX-FOXO1 fusion proteins in alveolar rhabdomyosarcoma using breakpoint specific monoclonal antibodies
David O. Azorsa et al.
MODERN PATHOLOGY (2021)
Pathology of childhood rhabdomyosarcoma: A consensus opinion document from the Children's Oncology Group, European Paediatric Soft Tissue Sarcoma Study Group, and the Cooperative Weichteilsarkom Studiengruppe
Erin R. Rudzinski et al.
PEDIATRIC BLOOD & CANCER (2021)
Complexity index in sarcoma and genomic grade index gene signatures in rhabdomyosarcoma of pediatric and adult ages
Andrea Ferrari et al.
PEDIATRIC BLOOD & CANCER (2021)
Infantile Rhabdomyosarcomas With VGLL2 Rearrangement Are Not Always an Indolent Disease A Study of 4 Aggressive Cases With Clinical, Pathologic, Molecular, and Radiologic Findings
Joanna Cyrta et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2021)
Frontiers in PROTACs
Gregory R. Hughes et al.
DRUG DISCOVERY TODAY (2021)
MYOD1 as a prognostic indicator in rhabdomyosarcoma
Atif A. Ahmed et al.
PEDIATRIC BLOOD & CANCER (2021)
Improving Risk Stratification for Pediatric Patients with Rhabdomyosarcoma by Molecular Detection of Disseminated Disease
Nathalie S. M. Lak et al.
CLINICAL CANCER RESEARCH (2021)
Novel fusion genes in spindle cell rhabdomyosarcoma: The spectrum broadens
Diego M. Montoya-Cerrillo et al.
GENES CHROMOSOMES & CANCER (2021)
Genomic Classification and Clinical Outcome in Rhabdomyosarcoma: A Report From an International Consortium
Jack F. Shern et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Vertical Pathway Inhibition Overcomes Adaptive Feedback Resistance to KRASG12C Inhibition
Meagan B. Ryan et al.
CLINICAL CANCER RESEARCH (2020)
Genomic Determinants of Clinical Outcomes in Rhabdomyosarcoma
Dana L. Casey et al.
CLINICAL CANCER RESEARCH (2020)
MammaPrint guides treatment decisions in breast Cancer: results of the IMPACt trial
Hatem Soliman et al.
BMC CANCER (2020)
Aurora A Kinase Inhibition Destabilizes PAX3-FOXO1 and MYCN and Synergizes with Navitoclax to Induce Rhabdomyosarcoma Cell Death
Johannes Ommer et al.
CANCER RESEARCH (2020)
Harmonizing Cell-Free DNA Collection and Processing Practices through Evidence-Based Guidance
Sarah R. Greytak et al.
CLINICAL CANCER RESEARCH (2020)
Prognostic Value of Circulating IGFBP2 and Related Autoantibodies in Children with Metastatic Rhabdomyosarcomas
Elena Poli et al.
DIAGNOSTICS (2020)
SRF-FOXO1 and SRF-NCOA1 Fusion Genes Delineate a Distinctive Subset of Well-differentiated Rhabdomyosarcoma
Marie Karanian et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2020)
Chimeric antigen receptor-modified T-cell therapy for platelet-derived growth factor receptor alpha-positive rhabdomyosarcoma
Wei Xiao et al.
CANCER (2020)
The Immunosuppressive Niche of Soft-Tissue Sarcomas is Sustained by Tumor-Associated Macrophages and Characterized by Intratumoral Tertiary Lymphoid Structures
Lingling Chen et al.
CLINICAL CANCER RESEARCH (2020)
Integrative clinical and biopathology analyses to understand the clinical heterogeneity of infantile rhabdomyosarcoma: A report from the French MMT committee
Thibault Butel et al.
CANCER MEDICINE (2020)
Comprehensive germline genomic profiles of children, adolescents and young adults with solid tumors
Sara Akhavanfard et al.
NATURE COMMUNICATIONS (2020)
A Global and Integrated Analysis of CINSARC-Associated Genetic Defects
Tom Lesluyes et al.
CANCER RESEARCH (2020)
Rhabdomyosarcoma associated with germline TP53 alteration in children and adolescents: The French experience
Morgane Pondrom et al.
PEDIATRIC BLOOD & CANCER (2020)
Long noncoding RNA functionality in imprinted domain regulation
William A. MacDonald et al.
PLOS GENETICS (2020)
Circulating miR-26a as Potential Prognostic Biomarkers in Pediatric Rhabdomyosarcoma
Lucia Tombolan et al.
FRONTIERS IN GENETICS (2020)
Novel FGFR4-Targeting Single-Domain Antibodies for Multiple Targeted Therapies against Rhabdomyosarcoma
Nagjie Alijaj et al.
CANCERS (2020)
Pediatric sarcomas display a variable EpCAM expression in a histology-dependent manner
Lucia Tombolan et al.
TRANSLATIONAL ONCOLOGY (2020)
MYOD1-mutant spindle cell and sclerosing rhabdomyosarcoma: an aggressive subtype irrespective of age. A reappraisal for molecular classification and risk stratification
Narasimhan P. Agaram et al.
MODERN PATHOLOGY (2019)
Genomic Imprinting and Physiological Processes in Mammals
Valter Tucci et al.
CELL (2019)
Early detection of the PAX3-FOXO1 fusion gene in circulating tumor-derived DNA in a case of alveolar rhabdomyosarcoma
Minenori Eguchi-Ishimae et al.
GENES CHROMOSOMES & CANCER (2019)
Neoplasm Risk Among Individuals With a Pathogenic Germline Variant in DICER1
Douglas R. Stewart et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Preclinical rationale for entinostat in embryonal rhabdomyosarcoma
Narendra Bharathy et al.
SKELETAL MUSCLE (2019)
Emerging trends in immunotherapy for pediatric sarcomas
Kyle A. Dyson et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
Congenital spindle cell rhabdomyosarcoma
Sarah B. Whittle et al.
PEDIATRIC BLOOD & CANCER (2019)
A tailored molecular profiling programme for children with cancer to identify clinically actionable genetic alterations
Sally L. George et al.
EUROPEAN JOURNAL OF CANCER (2019)
Refinement of risk stratification for childhood rhabdomyosarcoma using FOXO1 fusion status in addition to established clinical outcome predictors: A report from the Children's Oncology Group
Emily Hibbitts et al.
CANCER MEDICINE (2019)
The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity
Jude Canon et al.
NATURE (2019)
Histone hyperacetylation disrupts core gene regulatory architecture in rhabdomyosarcoma
Berkley E. Gryder et al.
NATURE GENETICS (2019)
Progress toward liquid biopsies in pediatric solid tumors
Daniel A. Weiser et al.
CANCER AND METASTASIS REVIEWS (2019)
Expanding the Spectrum of Intraosseous Rhabdomyosarcoma: Correlation Between 2 Distinct Gene Fusions and Phenotype
Narasimhan P. Agaram et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2019)
The tyrosine kinase inhibitor crizotinib does not have clinically meaningful activity in heavily pre-treated patients with advanced alveolar rhabdomyosarcoma with FOXO rearrangement: European Organisation for Research and Treatment of Cancer phase 2 trial 90101 'CREATE'
Patrick Schoffski et al.
EUROPEAN JOURNAL OF CANCER (2018)
Spindle cell rhabdomyosarcoma of bone with FUS-TFCP2 fusion: confirmation of a very recently described rhabdomyosarcoma subtype
Nooshi K. Dashti et al.
HISTOPATHOLOGY (2018)
New therapeutic strategies to treat human cancers expressing mutant p53 proteins
Giovanni Blandino et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
Transcriptomic definition of molecular subgroups of small round cell sarcomas
Sarah Watson et al.
JOURNAL OF PATHOLOGY (2018)
The landscape of genomic alterations across childhood cancers
Susanne N. Groebner et al.
NATURE (2018)
Functional screening of FGFR4-driven tumorigenesis identifies PI3K/mTOR inhibition as a therapeutic strategy in rhabdomyosarcoma
Timothy McKinnon et al.
ONCOGENE (2018)
Different Response of Ptch Mutant and Ptch Wildtype Rhabdomyosarcoma Toward SMO and PI3K Inhibitors
Natalie Geyer et al.
FRONTIERS IN ONCOLOGY (2018)
Discovery of Tetrahydropyridopyrimidines as Irreversible Covalent Inhibitors of KRAS-G12C with In Vivo Activity
Jay B. Fell et al.
ACS MEDICINAL CHEMISTRY LETTERS (2018)
Impact of fusion gene status versus histology on risk-stratification for rhabdomyosarcoma: Retrospective analyses of patients on UK trials
Joanna Selfe et al.
PEDIATRIC BLOOD & CANCER (2017)
PAX3-FOXO1 is essential for tumour initiation and maintenance but not recurrence in a human myoblast model of rhabdomyosarcoma
Puspa R. Pandey et al.
JOURNAL OF PATHOLOGY (2017)
Orthotopic patient-derived xenografts of paediatric solid tumours
Elizabeth Stewart et al.
NATURE (2017)
PAX3-FOXO1 Establishes Myogenic Super Enhancers and Confers BET Bromodomain Vulnerability
Berkley E. Gryder et al.
CANCER DISCOVERY (2017)
Development of a targeted sequencing approach to identify prognostic, predictive and diagnostic markers in paediatric solid tumours
Elisa Izquierdo et al.
ONCOTARGET (2017)
Recommendations for Childhood Cancer Screening and Surveillance in DNA Repair Disorders
Michael F. Walsh et al.
CLINICAL CANCER RESEARCH (2017)
A Molecular Study of Pediatric Spindle and Sclerosing Rhabdomyosarcoma Identification of Novel and Recurrent VGLL2-related Fusions in Infantile Cases
Rita Alaggio et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2016)
SARC009: Phase 2 study of dasatinib in patients with previously treated, high-grade, advanced sarcoma
Scott M. Schuetze et al.
CANCER (2016)
An Increased Risk of Second Malignant Neoplasms After Rhabdomyosarcoma: Population-based Evidence for a Cancer Predisposition Syndrome?
Natasha M. Archer et al.
PEDIATRIC BLOOD & CANCER (2016)
Paternal Uniparental Disomy with Segmental Loss of Heterozygosity of Chromosome 11 are Hallmark Characteristics of Syndromic and Sporadic Embryonal Rhabdomyosarcoma
Katherine M. Robbins et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2016)
Decreased CDKN1C Expression in Congenital Alveolar Rhabdomyosarcoma Associated with Beckwith-Wiedemann Syndrome
Fiammetta Piersigilli et al.
INDIAN JOURNAL OF PEDIATRICS (2016)
Sarcoma and germ-line DICER1 mutations Reply
Mandy L. Ballinger et al.
LANCET ONCOLOGY (2016)
MYOD1 (L122R) mutations are associated with spindle cell and sclerosing rhabdomyosarcomas with aggressive clinical outcomes
Bharat Rekhi et al.
MODERN PATHOLOGY (2016)
Histology, Fusion Status, and Outcome in Alveolar Rhabdomyosarcoma With Low-Risk Clinical Features: A Report From the Children's Oncology Group
Michael A. Arnold et al.
PEDIATRIC BLOOD & CANCER (2016)
Reduction of MDSCs with All-trans Retinoic Acid Improves CAR Therapy Efficacy for Sarcomas
Adrienne H. Long et al.
CANCER IMMUNOLOGY RESEARCH (2016)
Exosomes derived from embryonal and alveolar rhabdomyosarcoma carry differential miRNA cargo and promote invasion of recipient fibroblasts
Sandra E. Ghayad et al.
SCIENTIFIC REPORTS (2016)
The World Health Organization Classification of Skeletal Muscle Tumors in Pediatric Rhabdomyosarcoma A Report From the Children's Oncology Group
Erin R. Rudzinski et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2015)
Cancer spectrum and frequency among children with Noonan, Costello, and cardio-facio-cutaneous syndromes
C. P. Kratz et al.
BRITISH JOURNAL OF CANCER (2015)
Clinical Application of Prognostic Gene Expression Signature in Fusion Gene-Negative Rhabdomyosarcoma: A Report from the Children's Oncology Group
Pooja Hingorani et al.
CLINICAL CANCER RESEARCH (2015)
CDK4 Amplification Reduces Sensitivity to CDK4/6 Inhibition in Fusion-Positive Rhabdomyosarcoma
Mary E. Olanich et al.
CLINICAL CANCER RESEARCH (2015)
Integrative Clinical Sequencing in the Management of Refractory or Relapsed Cancer in Youth
Rajen J. Mody et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Myogenic Tumors in Nevoid Basal Cell Carcinoma Syndrome
Simone Hettmer et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2015)
Germline Mutations in Predisposition Genes in Pediatric Cancer
Jinghui Zhang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Rhabdomyosarcomas in children with neurofibromatosis type I: A national historical cohort
Anne Crucis et al.
PEDIATRIC BLOOD & CANCER (2015)
Integrated genetic and epigenetic analysis defines novel molecular subgroups in rhabdomyosarcoma
Masafumi Seki et al.
NATURE COMMUNICATIONS (2015)
Family history of cancer and childhood rhabdomyosarcoma: a report from the Children's Oncology Group and the Utah Population Database
Philip J. Lupo et al.
CANCER MEDICINE (2015)
PLK1 Phosphorylates PAX3-FOXO1, the Inhibition of Which Triggers Regression of Alveolar Rhabdomyosarcoma
Verena Thalhammer et al.
CANCER RESEARCH (2015)
Phase II Study of Cixutumumab in Combination With Temsirolimus in Pediatric Patients and Young Adults With Recurrent or Refractory Sarcoma: A Report From the Children's Oncology Group
Lars M. Wagner et al.
PEDIATRIC BLOOD & CANCER (2015)
IGF1R-and ROR1-Specific CAR T Cells as a Potential Therapy for High Risk Sarcomas
Xin Huang et al.
PLOS ONE (2015)
CTCF as a multifunctional protein in genome regulation and gene expression
Somi Kim et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2015)
Myogenin, AP2β, NOS-1, and HMGA2 Are Surrogate Markers of Fusion Status in Rhabdomyosarcoma A Report From the Soft Tissue Sarcoma Committee of the Children's Oncology Group
Erin R. Rudzinski et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2014)
Anaplastic Rhabdomyosarcoma in TP53 Germline Mutation Carriers
Simone Hettmer et al.
CANCER (2014)
A recurrent neomorphic mutation in MYOD1 defines a clinically aggressive subset of embryonal rhabdomyosarcoma associated with PI3K-AKT pathway mutations
Shinji Kohsaka et al.
NATURE GENETICS (2014)
Transformation by HrasG12V is consistently associated with mutant allele copy gains and is reversed by farnesyl transferase inhibition
X. Chen et al.
ONCOGENE (2014)
Comprehensive Genomic Analysis of Rhabdomyosarcoma Reveals a Landscape of Alterations Affecting a Common Genetic Axis in Fusion-Positive and Fusion-Negative Tumors
Jack F. Shern et al.
CANCER DISCOVERY (2014)
Targeting Oxidative Stress in Embryonal Rhabdomyosarcoma
Xiang Chen et al.
CANCER CELL (2013)
Dual Blockade of the PI3K/AKT/mTOR (AZD8055) and RAS/MEK/ERK (AZD6244) Pathways Synergistically Inhibits Rhabdomyosarcoma Cell Growth In Vitro and In Vivo
Jane Renshaw et al.
CLINICAL CANCER RESEARCH (2013)
A call to ARMS: targeting the PAX3-FOXO1 gene in alveolar rhabdomyosarcoma
Mary E. Olanich et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2013)
Recurrent NCOA2 gene rearrangements in congenital/infantile spindle cell rhabdomyosarcoma
Juan Miguel Mosquera et al.
GENES CHROMOSOMES & CANCER (2013)
PAX-FOXO1 fusion status drives unfavorable outcome for children with rhabdomyosarcoma: A children's oncology group report
Stephen X. Skapek et al.
PEDIATRIC BLOOD & CANCER (2013)
Cyclin-Dependent Kinase 4 Phosphorylates and Positively Regulates PAX3-FOXO1 in Human Alveolar Rhabdomyosarcoma Cells
Lingling Liu et al.
PLOS ONE (2013)
Sarcomas in TP53 Germline Mutation Carriers A Review of the IARC TP53 Database
Simona Ognjanovic et al.
CANCER (2012)
Oncogene Mutation Profiling of Pediatric Solid Tumors Reveals Significant Subsets of Embryonal Rhabdomyosarcoma and Neuroblastoma with Mutated Genes in Growth Signaling Pathways
Neerav Shukla et al.
CLINICAL CANCER RESEARCH (2012)
Questionable Universal Validity of PAX3/FOXO1 Fusion Gene Status As Molecular Marker for Improvement of Risk Stratification in Rhabdomyosarcoma Therapy
Sabine Stegmaier et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
PAX3/FOXO1 Fusion Gene Status Is the Key Prognostic Molecular Marker in Rhabdomyosarcoma and Significantly Improves Current Risk Stratification
Edoardo Missiaglia et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Prognostic Factors After Relapse in Nonmetastatic Rhabdomyosarcoma: A Nomogram to Better Define Patients Who Can Be Salvaged With Further Therapy
Julia C. Chisholm et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Prognostic Value of PAX-FKHR Fusion Status in Alveolar Rhabdomyosarcoma: A Report From the Cooperative Soft Tissue Sarcoma Study Group (CWS)
Sabine Stegmaier et al.
PEDIATRIC BLOOD & CANCER (2011)
Gene Expression Profiling for Survival Prediction in Pediatric Rhabdomyosarcomas: A Report From the Children's Oncology Group
Elai Davicioni et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Fusion Gene-Negative Alveolar Rhabdomyosarcoma Is Clinically and Molecularly Indistinguishable From Embryonal Rhabdomyosarcoma
Daniel Williamson et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Validated prediction of clinical outcome in sarcomas and multiple types of cancer on the basis of a gene expression signature related to genome complexity
Frederic Chibon et al.
NATURE MEDICINE (2010)
Molecular Classification of Rhabdomyosarcoma-Genotypic and Phenotypic Determinants of Diagnosis A Report from the Children's Oncology Group
Elai Davicioni et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Phosphorylation of Serine 205 by the Protein Kinase CK2 Persists on Pax3-FOXO1, but Not Pax3, throughout Early Myogenic Differentiation
Kevin N. Dietz et al.
BIOCHEMISTRY (2009)
Genomic and Clinical Analyses of 2p24 and 12q13-q14 Amplification in Alveolar Rhabdomyosarcoma: A Report from the Children's Oncology Group
Frederic G. Barr et al.
GENES CHROMOSOMES & CANCER (2009)
Comparing Adult and Pediatric Rhabdomyosarcoma in the Surveillance, Epidemiology and End Results Program, 1973 to 2005: An Analysis of 2,600 Patients
Iyad Sultan et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Manifestation of alveolar rhabdomyosarcoma as primary cutaneous lesions in a neonate with Beckwith-Wiedemann syndrome
Minoru Kuroiwa et al.
JOURNAL OF PEDIATRIC SURGERY (2009)
Prognostic factors in metastatic rhabdomyosarcomas: Results of a pooled analysis from United States and European cooperative groups
Odile Oberlin et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Soft-tissue sarcomas in children and adolescents with neurofibromatosis type 1
Andrea Ferrari et al.
CANCER (2007)
PAX3-FKHR and PAX7-FKHR fusion genes impact outcome of alveolar rhabdomyosarcoma in children
Bernarda Kazanowska et al.
FETAL AND PEDIATRIC PATHOLOGY (2007)
Identification of a PAX-FKHR gene expression signature that defines molecular classes and determines the prognosis of alveolar rhabdomyosarcomas
Elai Davicioni et al.
CANCER RESEARCH (2006)
Hypomethylation of the h19 gene causes not only Silver-Russell syndrome (SRS) but also isolated asymmetry or an SRS-like phenotype
J Bliek et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2006)
Subtype and prognostic classification of rhabdomyosarcoma by immunohistochemistry
M Wachtel et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Imprinting disruption of the CDKN1C/KCNQ10T1 domain: the molecular mechanisms causing Beckwith-Wiedemann syndrome and cancer
K. Higashimoto et al.
CYTOGENETIC AND GENOME RESEARCH (2006)
Tumor predisposition in Costello syndrome
KW Gripp
AMERICAN JOURNAL OF MEDICAL GENETICS PART C-SEMINARS IN MEDICAL GENETICS (2005)
Relationship between MYCN copy number and expression in rhabdomyosarcomas and correlation with adverse prognosis in the alveolar subtype
D Williamson et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Gene expression signatures identify rhabdomyosarcoma subtypes and detect a novel t(2;2)(q35;p23) translocation fusing PAX3 to NCOA1
M Wachtel et al.
CANCER RESEARCH (2004)
Neurofibromatosis in children with rhabdomyosarcoma: A report from the intergroup Rhabdomyosarcoma Study IV
L Sung et al.
JOURNAL OF PEDIATRICS (2004)
p53 and mdm-2 expression in rhabdomyosarcoma of childhood adolescence: Clinicopathologic study by the Kiel Pediatric Tumor Registry and the German Cooperative Soft Tissue Sarcoma Study
I Leuschner et al.
PEDIATRIC AND DEVELOPMENTAL PATHOLOGY (2003)
PAX3-FKHR and PAX7-FKHR gene fusions are prognostic indicators in alveolar rhabdomyosarcoma:: A report from the children's oncology group
PHB Sorensen et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Loss of methylation at chromosome 11p15.5 is common in human adult tumors
RAM Scelfo et al.
ONCOGENE (2002)
Association of alveolar rhabdomyosarcoma with the Beckwith-Wiedemann syndrome
AC Smith et al.
PEDIATRIC AND DEVELOPMENTAL PATHOLOGY (2001)
Increased tumour risk for BWS patients correlates with aberrant H19 and not KCNQ1OT1 methylation:: occurrence of KCNQ1OT1 hypomethylation in familial cases of BWS
J Bliek et al.
HUMAN MOLECULAR GENETICS (2001)
分享论文
